City State Bank’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5K | Hold |
250
| – | – | ﹤0.01% | 632 |
|
|
2025
Q1 | $3.4K | Hold |
250
| – | – | ﹤0.01% | 633 |
|
|
2024
Q4 | $5.1K | Hold |
250
| – | – | ﹤0.01% | 576 |
|
|
2024
Q3 | $7.28K | Hold |
250
| – | – | ﹤0.01% | 527 |
|
|
2024
Q2 | $5.81K | Hold |
250
| – | – | ﹤0.01% | 541 |
|
|
2024
Q1 | $5K | Hold |
250
| – | – | ﹤0.01% | 569 |
|
|
2023
Q4 | $5K | Hold |
250
| – | – | ﹤0.01% | 549 |
|
|
2023
Q3 | $5K | Hold |
250
| – | – | ﹤0.01% | 546 |
|
|
2023
Q2 | $7K | Hold |
250
| – | – | ﹤0.01% | 521 |
|
|
2023
Q1 | $6K | Hold |
250
| – | – | ﹤0.01% | 535 |
|
|
2022
Q4 | $7K | Hold |
250
| – | – | ﹤0.01% | 483 |
|
|
2022
Q3 | $8K | Hold |
250
| – | – | 0.01% | 457 |
|
|
2022
Q2 | $7K | Hold |
250
| – | – | ﹤0.01% | 488 |
|
|
2022
Q1 | $8K | Hold |
250
| – | – | ﹤0.01% | 497 |
|
|
2021
Q4 | $11K | Buy |
+250
| New | +$11K | 0.01% | 448 |
|